Blade Air Mobility, Inc. ( (BLDE) ) has released its Q2 earnings. Here is a breakdown of the information Blade Air Mobility, Inc. presented to its investors.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Blade Air Mobility, Inc. is a company that provides air transportation and logistics services, primarily focusing on medical transport and passenger flights, with a unique asset-light model and proprietary technologies aimed at transitioning to electric vertical aircraft. In its latest earnings report for the second quarter of 2025, Blade Air Mobility reported a 4.2% increase in total revenue to $70.8 million, driven by a significant 17.6% rise in medical revenue. The company also announced a strategic move to sell its Passenger division to Joby Aviation for up to $125 million, while its Medical division will continue as a standalone public entity under the new name Strata Critical Medical. Key financial highlights include an improvement in net loss by $7.6 million to $3.7 million and an increase in Adjusted EBITDA by $2.2 million to $3.2 million, reflecting strong performance in both the Passenger and Medical segments. As Blade transitions to Strata, the company is poised to focus on its core medical transport business, leveraging a partnership with Joby Aviation for future access to electric vertical takeoff and landing aircraft, which is expected to enhance its service offerings. Looking ahead, Blade’s management remains optimistic about the company’s growth prospects, supported by a robust financial position and strategic initiatives aimed at creating long-term value for stakeholders.